We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FND icon
651
Floor & Decor
FND
$6.14B
$2.62M 0.01%
20,122
+5,518
+38% +$711K
VCXAU
652
DELISTED
10X Capital Venture Acquisition Corp II Unit
VCXAU
$2.58M 0.01%
250,000
-250,000
-50% -$2.62M
KRNT icon
653
Kornit Digital
KRNT
$708M
$2.55M 0.01%
+16,747
New +$2.58M
MNTV
654
DELISTED
Momentive Global Inc. Common Stock
MNTV
$2.54M 0.01%
+120,000
New +$2.64M
PRBM.U
655
DELISTED
Parabellum Acquisition Corp. Units, each consisting of one share of Class A common stock and three-quarters of one redeemable warrant
PRBM.U
$2.54M 0.01%
250,000
AVACU
656
DELISTED
Avalon Acquisition Inc. Units
AVACU
$2.53M 0.01%
+250,000
New +$2.52M
ARNA
657
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.51M 0.01%
+27,000
New +$1.78M
MPRAU
658
DELISTED
Mercato Partners Acquisition Corporation Unit
MPRAU
$2.51M 0.01%
+250,000
New +$2.51M
INTEU
659
DELISTED
Integral Acquisition Corporation 1 Unit
INTEU
$2.5M 0.01%
+250,000
New +$2.51M
IBER.U
660
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$2.5M 0.01%
250,000
CRZNU
661
DELISTED
Corazon Capital V838 Monoceros Corp Unit
CRZNU
$2.5M 0.01%
250,000
GGMCU
662
DELISTED
Glenfarne Merger Corp. Unit
GGMCU
$2.48M 0.01%
250,000
FNVTU
663
DELISTED
Finnovate Acquisition Corp. Units
FNVTU
$2.48M 0.01%
+244,983
New +$2.48M
PMGMU
664
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$2.48M 0.01%
250,000
TWNI.U
665
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
$2.47M 0.01%
250,000
PSAGU
666
DELISTED
Property Solutions Acquisition Corporation II Units
PSAGU
$2.47M 0.01%
250,000
TRCA.U
667
DELISTED
Twin Ridge Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TRCA.U
$2.47M 0.01%
250,000
RCLFU
668
DELISTED
Rosecliff Acquisition Corp I Unit
RCLFU
$2.45M 0.01%
244,578
KRNL
669
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$2.44M 0.01%
250,000
MAQCU
670
DELISTED
Maquia Capital Acquisition Corporation Unit
MAQCU
$2.4M 0.01%
233,522
-16,478
-7% -$172K
AX icon
671
Axos Financial
AX
$5.64B
$2.38M 0.01%
+42,669
New +$2.39M
ROSEU
672
DELISTED
Rose Hill Acquisition Corporation Unit
ROSEU
$2.34M 0.01%
+230,805
New +$2.33M
ACAH
673
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$2.34M 0.01%
+240,000
New +$2.35M
MMP
674
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.31M 0.01%
49,660
RGEN icon
675
Repligen
RGEN
$7.11B
$2.3M 0.01%
8,671
+3,427
+65% +$923K

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.